The content is available as a PDF (333.3 KB).
Literatur
- 1.Darabi K et al (2006) Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts general hospital database and a review of the literature. Transfusion 46:741–753 [DOI] [PubMed]
- 2.Wong HK, et al. Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection. Transfusion. 2010;50:1967–1971. doi: 10.1111/j.1537-2995.2010.02651.x. [DOI] [PubMed] [Google Scholar]
- 3.Zhou B, et al. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J M. 2007;357:1450–1451. doi: 10.1056/NEJMc070359. [DOI] [PubMed] [Google Scholar]
- 4.Yeh KM, et al. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. J Antimicrob Chemother. 2005;56:919–922. doi: 10.1093/jac/dki346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Cheng Y, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24:44–46. doi: 10.1007/s10096-004-1271-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.WHO Blood Regulators Network (BRN) (2014) Position paper on collection and use of convalescent plasma or serum as an element in filovirus outbreak response. http://www.who.int/bloodproducts/brn/en/. Zugegriffen: 17. Juli 2015
- 7.Mupapa K, et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis. 1999;179(1):S. doi: 10.1086/514298. [DOI] [PubMed] [Google Scholar]
- 8.Emond RT, et al. A case of Ebola virus infection. Brit Med J. 1977;2:541–544. doi: 10.1136/bmj.2.6086.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Luke TC, et al. Meta-Analysis: Convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med. 2006;145:599–609. doi: 10.7326/0003-4819-145-8-200610170-00139. [DOI] [PubMed] [Google Scholar]
- 10.Hung IF, et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis. 2011;52:447–456. doi: 10.1093/cid/ciq106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sampath R, et al. Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Ann NY Aced Sci. 2007;1102:109–120. doi: 10.1196/annals.1408.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Delwart EL. Viral metagenomics. Rev Med Virol. 2007;17:115–131. doi: 10.1002/rmv.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Svraka S, et al. Metagenomic sequencing for virus identification in a public-health setting. J Gen Virol. 2010;91:2846–2856. doi: 10.1099/vir.0.024612-0. [DOI] [PubMed] [Google Scholar]
- 14.vgl. z. B. http://www.nibsc.org/products/biological_reference_materials/product_catalogue/sub_category_listing.aspx?category=diagnostics&subcategory=Immunoglobulins+and+immune+sera. Zugegriffen: 17. Juli 2015
- 15.http://www.who.int/csr/outbreaknetwork/en/. Zugegriffen: 17. Juli 2015
- 16.World Health Organisation (2014) Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. Interim Guidance for National Health Authorities and Blood Transfusion Services. Version 1.0. Zugegriffen: 17. Juli 2015
- 17.Änderung einer Bekanntmachung über die Zulassung von Arzneimitteln (Verkürzung der Quarantänelagerung von Frischplasma) vom 27. Februar 2003, Bundesanzeiger Nr. 60 vom 27. März 2003, S 5620. http://www.pei.de/SharedDocs/bekanntmachungen/2003/banz-60-27-03-2003-s5620.html. Zugegriffen: 17. Juli 2015